Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on October 6, 2026

Oct. 6, 2026

Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy

Indeterminate GlobeNewswire

Oct. 6, 2026

First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)

Indeterminate GlobeNewswire

Oct. 6, 2026

Trial Lawyer Fraud Ring Accusations Exposed

Indeterminate GlobeNewswire

Oct. 6, 2026

Minerva Humanoids Emerges From Stealth With $10M Pre-Seed Round Led by General Catalyst to Build Humanoid Robots for the World's Most Dangerous Jobs

Indeterminate GlobeNewswire

Oct. 6, 2026

Zscaler Hosts 2026 Investor Day, Reaffirms First Quarter and Fiscal 2027 Guidance

Indeterminate GlobeNewswire

Oct. 6, 2026

Applied Digital Secures Up to 1 GW of Potential Power Capacity in Finland, Marking First International Development in the Nordics

Indeterminate GlobeNewswire

Oct. 6, 2026

MediciNova to Participate in the Maxim Growth Summit

Indeterminate GlobeNewswire

Oct. 6, 2026

Blossom Gold Announces a Gold Discovery on the Kamma Claims  

Indeterminate GlobeNewswire

Oct. 6, 2026

PathMaker Neurosystems Announces Publication of First-Ever Study Showing Non-Invasive Clearance of Toxic TDP-43 Protein Aggregates in Preclinical ALS Study

Indeterminate GlobeNewswire

Oct. 6, 2026

Roadzen to Present at Maxim Growth Summit and ThinkEquity Conference

Indeterminate GlobeNewswire

Oct. 6, 2026

Much more than promotion in construction: 12Build supports subcontractors through the entire bidding process

Indeterminate GlobeNewswire

Oct. 6, 2026

Veel meer dan promotie in de bouw: 12Build ondersteunt bouwspecialisten in het héle biedingsproces

Indeterminate GlobeNewswire

Oct. 6, 2026

Resolution Therapeutics to present interim Phase I/II EMERALD study data on RTX001 as a late-breaker at AASLD 2026

Indeterminate GlobeNewswire

Oct. 6, 2026

Caseware Verity-Powered Risk Suggestion Agent Launches to Help Auditors Identify Engagement-Specific Risks

Indeterminate GlobeNewswire

Oct. 6, 2026

RQ Bio Appoints Gavin Koh as Chief Medical Officer and Strengthens Leadership to Advance RQB01

Indeterminate GlobeNewswire

Oct. 6, 2026

Angelini Ventures and EIB Co-lead $58 Million Series A Financing in Rouge Therapeutics to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia

Indeterminate GlobeNewswire

Oct. 6, 2026

Rewind Therapeutics Secures Additional Financing to Advance Oral GPR17 Remyelination Program

Indeterminate GlobeNewswire

Oct. 6, 2026

RougeTx Launches with $58 Million Series A Financing to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia

Indeterminate GlobeNewswire

Oct. 6, 2026

Jeppesen ForeFlight Airflow™ Agents Debut for Commercial Aviation, Centered on Operating Intelligence and Adoption Flexibility

Indeterminate GlobeNewswire

Oct. 6, 2026

Canada’s project boom could generate $443B in revenues for SMEs: BDC study

Indeterminate GlobeNewswire